JP2006525329A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006525329A5 JP2006525329A5 JP2006509981A JP2006509981A JP2006525329A5 JP 2006525329 A5 JP2006525329 A5 JP 2006525329A5 JP 2006509981 A JP2006509981 A JP 2006509981A JP 2006509981 A JP2006509981 A JP 2006509981A JP 2006525329 A5 JP2006525329 A5 JP 2006525329A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- phenyl
- biphenyl
- benzyl
- benzofuran
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 R 21 Chemical compound 0.000 claims 36
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 31
- 229910052736 halogen Inorganic materials 0.000 claims 27
- 150000002367 halogens Chemical class 0.000 claims 27
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 24
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 16
- 125000000217 alkyl group Chemical group 0.000 claims 15
- 150000001875 compounds Chemical class 0.000 claims 15
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 claims 12
- 125000004438 haloalkoxy group Chemical group 0.000 claims 10
- 125000001188 haloalkyl group Chemical group 0.000 claims 10
- 125000005037 alkyl phenyl group Chemical group 0.000 claims 9
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 claims 7
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims 7
- 125000003118 aryl group Chemical group 0.000 claims 7
- 125000003545 alkoxy group Chemical group 0.000 claims 6
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims 6
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 4
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 4
- 239000000126 substance Substances 0.000 claims 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 4
- 125000002252 acyl group Chemical group 0.000 claims 3
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 3
- 125000004122 cyclic group Chemical group 0.000 claims 3
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 claims 3
- 125000001041 indolyl group Chemical group 0.000 claims 3
- 125000001624 naphthyl group Chemical group 0.000 claims 3
- 125000003386 piperidinyl group Chemical group 0.000 claims 3
- 125000004076 pyridyl group Chemical group 0.000 claims 3
- BCAPAVNRPJLWBU-UHFFFAOYSA-N 2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]sulfonylamino]butanoic acid Chemical compound C1=CC(S(=O)(=O)NC(CC)C(O)=O)=CC=C1C1=CC=C(C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)C=C1 BCAPAVNRPJLWBU-UHFFFAOYSA-N 0.000 claims 2
- WAKZELVPMHJKIX-UHFFFAOYSA-N 2-benzyl-4-[2-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]-4-oxobutanoic acid Chemical compound C=1C=CC=CC=1CC(C(=O)O)CC(=O)C1=CC=CC=C1C(C=C1)=CC=C1C(C1=CC=CC=C1O1)=C1CC1=CC=CC=C1 WAKZELVPMHJKIX-UHFFFAOYSA-N 0.000 claims 2
- VCOJXFLHAWTRFN-UHFFFAOYSA-N 2-benzyl-4-[3-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]-4-oxobutanoic acid Chemical compound C=1C=CC=CC=1CC(C(=O)O)CC(=O)C(C=1)=CC=CC=1C(C=C1)=CC=C1C(C1=CC=CC=C1O1)=C1CC1=CC=CC=C1 VCOJXFLHAWTRFN-UHFFFAOYSA-N 0.000 claims 2
- MPXRREHOMCUVNZ-UHFFFAOYSA-N 2-benzyl-4-[4-(4-indol-1-ylphenyl)phenyl]-4-oxobutanoic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)N2C3=CC=CC=C3C=C2)C=CC=1C(=O)CC(C(=O)O)CC1=CC=CC=C1 MPXRREHOMCUVNZ-UHFFFAOYSA-N 0.000 claims 2
- WLXCNKISKIXXST-UHFFFAOYSA-N 2-benzyl-4-[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]-2,6-dimethylphenyl]-4-oxobutanoic acid Chemical compound CC1=CC(C=2C=CC(=CC=2)C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)=CC(C)=C1C(=O)CC(C(O)=O)CC1=CC=CC=C1 WLXCNKISKIXXST-UHFFFAOYSA-N 0.000 claims 2
- FOUKSPNWVQXNSE-UHFFFAOYSA-N 4-[4-(4-dibenzofuran-4-ylphenyl)phenyl]-4-oxo-2-[[3-(trifluoromethyl)phenyl]methyl]butanoic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=C(C4=CC=CC=C4O3)C=CC=2)C=CC=1C(=O)CC(C(=O)O)CC1=CC=CC(C(F)(F)F)=C1 FOUKSPNWVQXNSE-UHFFFAOYSA-N 0.000 claims 2
- JZUWBNLKHMQGNS-UHFFFAOYSA-N 4-[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]-2-[(4-methylsulfonylphenyl)methyl]-4-oxobutanoic acid Chemical compound C1=CC(S(=O)(=O)C)=CC=C1CC(C(O)=O)CC(=O)C1=CC=C(C=2C=CC(=CC=2)C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)C=C1 JZUWBNLKHMQGNS-UHFFFAOYSA-N 0.000 claims 2
- QNYLAIBEHNOPPA-UHFFFAOYSA-N 4-[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]-2-[2-(1,3-dioxoisoindol-2-yl)ethyl]-4-oxobutanoic acid Chemical compound O=C1C2=CC=CC=C2C(=O)N1CCC(C(=O)O)CC(=O)C(C=C1)=CC=C1C(C=C1)=CC=C1C(C1=CC=CC=C1O1)=C1CC1=CC=CC=C1 QNYLAIBEHNOPPA-UHFFFAOYSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 2
- 235000004279 alanine Nutrition 0.000 claims 2
- 125000002877 alkyl aryl group Chemical group 0.000 claims 2
- 125000005605 benzo group Chemical group 0.000 claims 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 2
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical compound C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 claims 2
- 125000004988 dibenzothienyl group Chemical group C1(=CC=CC=2SC3=C(C21)C=CC=C3)* 0.000 claims 2
- UTCSSFWDNNEEBH-UHFFFAOYSA-N imidazo[1,2-a]pyridine Chemical compound C1=CC=CC2=NC=CN21 UTCSSFWDNNEEBH-UHFFFAOYSA-N 0.000 claims 2
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000002757 morpholinyl group Chemical group 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 229960005190 phenylalanine Drugs 0.000 claims 2
- 125000005545 phthalimidyl group Chemical group 0.000 claims 2
- 125000005400 pyridylcarbonyl group Chemical group N1=C(C=CC=C1)C(=O)* 0.000 claims 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 125000001544 thienyl group Chemical group 0.000 claims 2
- GSJVCQGPHKZZTL-JGCGQSQUSA-N (2R)-2,5-diamino-2-[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]-2-nitrophenyl]-5-oxopentanoic acid Chemical compound C(C1=CC=CC=C1)C=1OC2=C(C=1C1=CC=C(C=C1)C1=CC(=C(C=C1)[C@](N)(CCC(N)=O)C(=O)O)[N+](=O)[O-])C=CC=C2 GSJVCQGPHKZZTL-JGCGQSQUSA-N 0.000 claims 1
- RVJUPLWFUPACJL-JGCGQSQUSA-N (2r)-2-[4-[4-(1-butylindolizin-2-yl)phenyl]phenoxy]-3-phenylpropanoic acid Chemical compound C([C@@H](OC1=CC=C(C=C1)C1=CC=C(C=C1)C=1C(=C2C=CC=CN2C=1)CCCC)C(O)=O)C1=CC=CC=C1 RVJUPLWFUPACJL-JGCGQSQUSA-N 0.000 claims 1
- ALOFTPNNFBMPOW-MGBGTMOVSA-N (2r)-2-[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]-n-methyl-2-nitroanilino]-3-phenylpropanoic acid Chemical compound C([C@@H](N(C)C=1C(=CC(=CC=1)C=1C=CC(=CC=1)C=1C2=CC=CC=C2OC=1CC=1C=CC=CC=1)[N+]([O-])=O)C(O)=O)C1=CC=CC=C1 ALOFTPNNFBMPOW-MGBGTMOVSA-N 0.000 claims 1
- QXMNORFCWALUQG-XIFFEERXSA-N (2s)-2-[4-[4-(1-butylindolizin-2-yl)phenyl]phenoxy]-4-phenylbutanoic acid Chemical compound C([C@H](OC1=CC=C(C=C1)C1=CC=C(C=C1)C=1C(=C2C=CC=CN2C=1)CCCC)C(O)=O)CC1=CC=CC=C1 QXMNORFCWALUQG-XIFFEERXSA-N 0.000 claims 1
- LBHTUNQLUBVJPB-KDXMTYKHSA-N (2s)-2-[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]-2-[(2-phenylacetyl)amino]anilino]-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NC=1C(=CC(=CC=1)C=1C=CC(=CC=1)C=1C2=CC=CC=C2OC=1CC=1C=CC=CC=1)NC(=O)CC=1C=CC=CC=1)C1=CC=CC=C1 LBHTUNQLUBVJPB-KDXMTYKHSA-N 0.000 claims 1
- TVGXOXUAFKXOQE-VWLOTQADSA-N (2s)-2-[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]-2-nitroanilino]-3-hydroxypropanoic acid Chemical compound C1=C([N+]([O-])=O)C(N[C@@H](CO)C(O)=O)=CC=C1C1=CC=C(C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)C=C1 TVGXOXUAFKXOQE-VWLOTQADSA-N 0.000 claims 1
- VZQPGBMZSRZGNS-HKBQPEDESA-N (2s)-2-[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]-2-nitroanilino]-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NC=1C(=CC(=CC=1)C=1C=CC(=CC=1)C=1C2=CC=CC=C2OC=1CC=1C=CC=CC=1)[N+]([O-])=O)C1=CC=CC=C1 VZQPGBMZSRZGNS-HKBQPEDESA-N 0.000 claims 1
- PLDAFOFKTYIKNJ-MHZLTWQESA-N (2s)-2-[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]-2-nitroanilino]-4-methylsulfanylbutanoic acid Chemical compound C1=C([N+]([O-])=O)C(N[C@@H](CCSC)C(O)=O)=CC=C1C1=CC=C(C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)C=C1 PLDAFOFKTYIKNJ-MHZLTWQESA-N 0.000 claims 1
- CTHQHLFBRGKYCW-PMERELPUSA-N (2s)-2-[4-[4-(2-benzyl-4-fluoro-1-benzofuran-3-yl)phenyl]-2-nitroanilino]-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NC=1C(=CC(=CC=1)C=1C=CC(=CC=1)C=1C2=C(F)C=CC=C2OC=1CC=1C=CC=CC=1)[N+]([O-])=O)C1=CC=CC=C1 CTHQHLFBRGKYCW-PMERELPUSA-N 0.000 claims 1
- JIZSLXVSDDGOQR-DHUJRADRSA-N (2s)-2-[4-[4-[(2-benzyl-7-ethoxy-1-benzofuran-4-yl)methyl]phenyl]-2-nitroanilino]-3-phenylpropanoic acid Chemical compound C([C@H](NC1=CC=C(C=C1[N+]([O-])=O)C1=CC=C(C=C1)CC1=CC=C(C=2OC(CC=3C=CC=CC=3)=CC=21)OCC)C(O)=O)C1=CC=CC=C1 JIZSLXVSDDGOQR-DHUJRADRSA-N 0.000 claims 1
- SKVKSLAIKOIQDV-HKBQPEDESA-N (2s)-2-[[4-[4-(1-butylindolizin-2-yl)phenyl]benzoyl]amino]-3-phenylpropanoic acid Chemical compound C([C@H](NC(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)C=1C(=C2C=CC=CN2C=1)CCCC)C(O)=O)C1=CC=CC=C1 SKVKSLAIKOIQDV-HKBQPEDESA-N 0.000 claims 1
- YAMKTWOCIRVYGC-HKBQPEDESA-N (2s)-2-[[4-[4-(1-butylindolizin-2-yl)phenyl]phenyl]sulfonylamino]-3-phenylpropanoic acid Chemical compound C([C@H](NS(=O)(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)C=1C(=C2C=CC=CN2C=1)CCCC)C(O)=O)C1=CC=CC=C1 YAMKTWOCIRVYGC-HKBQPEDESA-N 0.000 claims 1
- JBPANPVYVLBQAD-YTTGMZPUSA-N (2s)-2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]-2-fluorophenyl]sulfonyl-methylamino]-3-phenylpropanoic acid Chemical compound C([C@H](N(C)S(=O)(=O)C=1C(=CC(=CC=1)C=1C=CC(=CC=1)C=1C2=CC=CC=C2OC=1CC=1C=CC=CC=1)F)C(O)=O)C1=CC=CC=C1 JBPANPVYVLBQAD-YTTGMZPUSA-N 0.000 claims 1
- LJPVNLNUYKHZES-HKBQPEDESA-N (2s)-2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]-2-fluorophenyl]sulfonylamino]-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NS(=O)(=O)C=1C(=CC(=CC=1)C=1C=CC(=CC=1)C=1C2=CC=CC=C2OC=1CC=1C=CC=CC=1)F)C1=CC=CC=C1 LJPVNLNUYKHZES-HKBQPEDESA-N 0.000 claims 1
- YTZDCEHZTQGKTO-YTTGMZPUSA-N (2s)-2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]benzoyl]-methylamino]-3-methylbutanoic acid Chemical compound C1=CC(C(=O)N(C)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=C(C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)C=C1 YTZDCEHZTQGKTO-YTTGMZPUSA-N 0.000 claims 1
- QEYCNFONUGAJSK-XIFFEERXSA-N (2s)-2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]benzoyl]-methylamino]-3-phenylpropanoic acid Chemical compound C([C@H](N(C)C(=O)C=1C=CC(=CC=1)C=1C=CC(=CC=1)C=1C2=CC=CC=C2OC=1CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 QEYCNFONUGAJSK-XIFFEERXSA-N 0.000 claims 1
- DBWYMVBSMCVXFS-YTTGMZPUSA-N (2s)-2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]benzoyl]amino]-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C=1C=CC(=CC=1)C=1C=CC(=CC=1)C=1C2=CC=CC=C2OC=1CC=1C=CC=CC=1)C1=CC=CC=C1 DBWYMVBSMCVXFS-YTTGMZPUSA-N 0.000 claims 1
- NHIMACVYYZIWJC-UMSFTDKQSA-N (2s)-2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]sulfonyl-ethylamino]-3-(4-fluorophenyl)propanoic acid Chemical compound C([C@H](N(CC)S(=O)(=O)C=1C=CC(=CC=1)C=1C=CC(=CC=1)C=1C2=CC=CC=C2OC=1CC=1C=CC=CC=1)C(O)=O)C1=CC=C(F)C=C1 NHIMACVYYZIWJC-UMSFTDKQSA-N 0.000 claims 1
- NNFVGFXSJCCBRK-XIFFEERXSA-N (2s)-2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]sulfonyl-methylamino]-3-(3-fluorophenyl)propanoic acid Chemical compound C([C@H](N(C)S(=O)(=O)C=1C=CC(=CC=1)C=1C=CC(=CC=1)C=1C2=CC=CC=C2OC=1CC=1C=CC=CC=1)C(O)=O)C1=CC=CC(F)=C1 NNFVGFXSJCCBRK-XIFFEERXSA-N 0.000 claims 1
- ZRECXQDSNGZOPR-XIFFEERXSA-N (2s)-2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]sulfonyl-methylamino]-3-(4-fluorophenyl)propanoic acid Chemical compound C([C@H](N(C)S(=O)(=O)C=1C=CC(=CC=1)C=1C=CC(=CC=1)C=1C2=CC=CC=C2OC=1CC=1C=CC=CC=1)C(O)=O)C1=CC=C(F)C=C1 ZRECXQDSNGZOPR-XIFFEERXSA-N 0.000 claims 1
- DUJKEHAVYGLFTH-XIFFEERXSA-N (2s)-2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]sulfonyl-methylamino]-3-phenylpropanoic acid Chemical compound C([C@H](N(C)S(=O)(=O)C=1C=CC(=CC=1)C=1C=CC(=CC=1)C=1C2=CC=CC=C2OC=1CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 DUJKEHAVYGLFTH-XIFFEERXSA-N 0.000 claims 1
- ZVKRFSNAJWLMPK-YTTGMZPUSA-N (2s)-2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]sulfonylamino]-3-(3-fluorophenyl)propanoic acid Chemical compound C([C@@H](C(=O)O)NS(=O)(=O)C=1C=CC(=CC=1)C=1C=CC(=CC=1)C=1C2=CC=CC=C2OC=1CC=1C=CC=CC=1)C1=CC=CC(F)=C1 ZVKRFSNAJWLMPK-YTTGMZPUSA-N 0.000 claims 1
- MXGLLBXKUZEPRM-YTTGMZPUSA-N (2s)-2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]sulfonylamino]-3-(4-fluorophenyl)propanoic acid Chemical compound C([C@@H](C(=O)O)NS(=O)(=O)C=1C=CC(=CC=1)C=1C=CC(=CC=1)C=1C2=CC=CC=C2OC=1CC=1C=CC=CC=1)C1=CC=C(F)C=C1 MXGLLBXKUZEPRM-YTTGMZPUSA-N 0.000 claims 1
- POXAPKDSOPLBBL-YTTGMZPUSA-N (2s)-2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]sulfonylamino]-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NS(=O)(=O)C=1C=CC(=CC=1)C=1C=CC(=CC=1)C=1C2=CC=CC=C2OC=1CC=1C=CC=CC=1)C1=CC=CC=C1 POXAPKDSOPLBBL-YTTGMZPUSA-N 0.000 claims 1
- NOCKIGVUZLZBOZ-NDEPHWFRSA-N (2s)-2-[[4-[4-(5-methylindol-1-yl)phenyl]benzoyl]amino]-3-phenylpropanoic acid Chemical compound C([C@H](NC(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)N1C2=CC=C(C=C2C=C1)C)C(O)=O)C1=CC=CC=C1 NOCKIGVUZLZBOZ-NDEPHWFRSA-N 0.000 claims 1
- QVQXHODTLOOOCB-YTTGMZPUSA-N (2s)-2-[[4-[4-[(2-butyl-1-benzofuran-3-yl)methyl]phenyl]benzoyl]-methylamino]-3-phenylpropanoic acid Chemical compound C([C@H](N(C)C(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)CC=1C2=CC=CC=C2OC=1CCCC)C(O)=O)C1=CC=CC=C1 QVQXHODTLOOOCB-YTTGMZPUSA-N 0.000 claims 1
- JYDNEWUUQHTPMP-YTTGMZPUSA-N (2s)-2-[[4-[4-[(2-butyl-1-benzofuran-3-yl)methyl]phenyl]phenyl]sulfonyl-methylamino]-3-phenylpropanoic acid Chemical compound C([C@H](N(C)S(=O)(=O)C1=CC=C(C=C1)C1=CC=C(C=C1)CC=1C2=CC=CC=C2OC=1CCCC)C(O)=O)C1=CC=CC=C1 JYDNEWUUQHTPMP-YTTGMZPUSA-N 0.000 claims 1
- LIKQUXALWNYQST-UHFFFAOYSA-N 2-[2-chloro-4-(4-dibenzofuran-4-ylphenyl)phenoxy]-2-phenylacetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=C(C4=CC=CC=C4O3)C=CC=2)C=C(Cl)C=1OC(C(=O)O)C1=CC=CC=C1 LIKQUXALWNYQST-UHFFFAOYSA-N 0.000 claims 1
- LHKBJCSEDWDFQU-UHFFFAOYSA-N 2-[3-chloro-4-(4-dibenzofuran-4-ylphenyl)phenoxy]-2-phenylacetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=C(C4=CC=CC=C4O3)C=CC=2)C(Cl)=CC=1OC(C(=O)O)C1=CC=CC=C1 LHKBJCSEDWDFQU-UHFFFAOYSA-N 0.000 claims 1
- UHAOLYKGVURGHY-UHFFFAOYSA-N 2-[4-(1-benzylindol-6-yl)phenoxy]-2-phenylacetic acid Chemical compound C=1C=CC=CC=1C(C(=O)O)OC(C=C1)=CC=C1C(C=C12)=CC=C1C=CN2CC1=CC=CC=C1 UHAOLYKGVURGHY-UHFFFAOYSA-N 0.000 claims 1
- XNIYTDCYFRYSBN-UHFFFAOYSA-N 2-[4-(4-dibenzofuran-4-ylphenyl)-2-fluorophenoxy]-2-phenylacetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=C(C4=CC=CC=C4O3)C=CC=2)C=C(F)C=1OC(C(=O)O)C1=CC=CC=C1 XNIYTDCYFRYSBN-UHFFFAOYSA-N 0.000 claims 1
- QQYFRIAAVHUCJW-UHFFFAOYSA-N 2-[4-(4-dibenzofuran-4-ylphenyl)-3-(trifluoromethyl)phenoxy]-2-phenylacetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=C(C4=CC=CC=C4O3)C=CC=2)C(C(F)(F)F)=CC=1OC(C(=O)O)C1=CC=CC=C1 QQYFRIAAVHUCJW-UHFFFAOYSA-N 0.000 claims 1
- GSUCSJIGNHMJKC-UHFFFAOYSA-N 2-[4-(4-dibenzofuran-4-ylphenyl)-3-methylphenoxy]-2-phenylacetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=C(C4=CC=CC=C4O3)C=CC=2)C(C)=CC=1OC(C(O)=O)C1=CC=CC=C1 GSUCSJIGNHMJKC-UHFFFAOYSA-N 0.000 claims 1
- OZTCLTRYZGGMDA-UHFFFAOYSA-N 2-[4-(4-dibenzofuran-4-ylphenyl)phenoxy]-2-phenylacetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=C(C4=CC=CC=C4O3)C=CC=2)C=CC=1OC(C(=O)O)C1=CC=CC=C1 OZTCLTRYZGGMDA-UHFFFAOYSA-N 0.000 claims 1
- RKZNTKWULWPQCU-UHFFFAOYSA-N 2-[4-(4-dibenzothiophen-4-ylphenyl)phenoxy]-2-phenylacetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=C(C4=CC=CC=C4S3)C=CC=2)C=CC=1OC(C(=O)O)C1=CC=CC=C1 RKZNTKWULWPQCU-UHFFFAOYSA-N 0.000 claims 1
- PVFRKJHMBYMZRC-UHFFFAOYSA-N 2-[4-(4-indol-1-ylphenyl)phenoxy]-2-phenylacetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)N2C3=CC=CC=C3C=C2)C=CC=1OC(C(=O)O)C1=CC=CC=C1 PVFRKJHMBYMZRC-UHFFFAOYSA-N 0.000 claims 1
- SQMLYPGVSZMVOH-UHFFFAOYSA-N 2-[4-[4-(1-benzofuran-2-yl)phenyl]phenoxy]-2-phenylacetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2OC3=CC=CC=C3C=2)C=CC=1OC(C(=O)O)C1=CC=CC=C1 SQMLYPGVSZMVOH-UHFFFAOYSA-N 0.000 claims 1
- UTEAUCDPBZAWGI-UHFFFAOYSA-N 2-[4-[4-(1-benzothiophen-2-yl)phenyl]phenoxy]-2-phenylacetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2SC3=CC=CC=C3C=2)C=CC=1OC(C(=O)O)C1=CC=CC=C1 UTEAUCDPBZAWGI-UHFFFAOYSA-N 0.000 claims 1
- KSKAMSSJHOSHJP-UHFFFAOYSA-N 2-[4-[4-(1-benzothiophen-3-yl)phenyl]phenoxy]-2-phenylacetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=CC=CC=C3SC=2)C=CC=1OC(C(=O)O)C1=CC=CC=C1 KSKAMSSJHOSHJP-UHFFFAOYSA-N 0.000 claims 1
- HHLFYYQYYWYHRW-UHFFFAOYSA-N 2-[4-[4-(1-benzylindol-5-yl)phenyl]phenoxy]-2-phenylacetic acid Chemical compound C=1C=CC=CC=1C(C(=O)O)OC(C=C1)=CC=C1C(C=C1)=CC=C1C(C=C1C=C2)=CC=C1N2CC1=CC=CC=C1 HHLFYYQYYWYHRW-UHFFFAOYSA-N 0.000 claims 1
- HPFDHHJGMMESOA-UHFFFAOYSA-N 2-[4-[4-(1-benzylindol-6-yl)phenyl]phenoxy]-2-phenylacetic acid Chemical compound C=1C=CC=CC=1C(C(=O)O)OC(C=C1)=CC=C1C(C=C1)=CC=C1C(C=C12)=CC=C1C=CN2CC1=CC=CC=C1 HPFDHHJGMMESOA-UHFFFAOYSA-N 0.000 claims 1
- QCVMHQBNRWYXOD-UHFFFAOYSA-N 2-[4-[4-(1-butylindolizin-2-yl)phenyl]anilino]-2-phenylacetic acid Chemical compound C=1N2C=CC=CC2=C(CCCC)C=1C(C=C1)=CC=C1C(C=C1)=CC=C1NC(C(O)=O)C1=CC=CC=C1 QCVMHQBNRWYXOD-UHFFFAOYSA-N 0.000 claims 1
- QJPDJMOOIBYJFT-UHFFFAOYSA-N 2-[4-[4-(1-butylindolizin-2-yl)phenyl]phenoxy]-2-phenylacetic acid Chemical compound C=1N2C=CC=CC2=C(CCCC)C=1C(C=C1)=CC=C1C(C=C1)=CC=C1OC(C(O)=O)C1=CC=CC=C1 QJPDJMOOIBYJFT-UHFFFAOYSA-N 0.000 claims 1
- DTLZRYDPCAKNOU-UHFFFAOYSA-N 2-[4-[4-(1-butylindolizin-2-yl)phenyl]phenoxy]propanoic acid Chemical compound C=1N2C=CC=CC2=C(CCCC)C=1C(C=C1)=CC=C1C1=CC=C(OC(C)C(O)=O)C=C1 DTLZRYDPCAKNOU-UHFFFAOYSA-N 0.000 claims 1
- FESFWYIPANZSEP-UHFFFAOYSA-N 2-[4-[4-(1-butylindolizin-2-yl)phenyl]phenyl]sulfonyl-2-phenylacetic acid Chemical compound C=1N2C=CC=CC2=C(CCCC)C=1C(C=C1)=CC=C1C(C=C1)=CC=C1S(=O)(=O)C(C(O)=O)C1=CC=CC=C1 FESFWYIPANZSEP-UHFFFAOYSA-N 0.000 claims 1
- VZQPGBMZSRZGNS-UHFFFAOYSA-N 2-[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]-2-nitroanilino]-3-phenylpropanoic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)C=C([N+]([O-])=O)C=1NC(C(=O)O)CC1=CC=CC=C1 VZQPGBMZSRZGNS-UHFFFAOYSA-N 0.000 claims 1
- CBAKPPAEHFOGJA-UHFFFAOYSA-N 2-[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenoxy]-3-phenylpropanoic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)C=CC=1OC(C(=O)O)CC1=CC=CC=C1 CBAKPPAEHFOGJA-UHFFFAOYSA-N 0.000 claims 1
- PUBMZUOBSIJWOM-UHFFFAOYSA-N 2-[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenoxy]propanoic acid Chemical compound C1=CC(OC(C)C(O)=O)=CC=C1C1=CC=C(C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)C=C1 PUBMZUOBSIJWOM-UHFFFAOYSA-N 0.000 claims 1
- CPNWIHWVKIGEIY-UHFFFAOYSA-N 2-[4-[4-(5-chloroindol-1-yl)phenyl]phenoxy]-2-phenylacetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)N2C3=CC=C(Cl)C=C3C=C2)C=CC=1OC(C(=O)O)C1=CC=CC=C1 CPNWIHWVKIGEIY-UHFFFAOYSA-N 0.000 claims 1
- ZNNQOHFMKNTICX-UHFFFAOYSA-N 2-[4-[4-(5-methylindol-1-yl)phenyl]phenoxy]-2-phenylacetic acid Chemical compound C1=CC2=CC(C)=CC=C2N1C(C=C1)=CC=C1C(C=C1)=CC=C1OC(C(O)=O)C1=CC=CC=C1 ZNNQOHFMKNTICX-UHFFFAOYSA-N 0.000 claims 1
- QQNUVDFADZMUMM-UHFFFAOYSA-N 2-[4-[4-[(9-oxofluoren-1-yl)oxymethyl]phenyl]phenoxy]-2-phenylacetic acid Chemical compound C=1C=C(C=2C=CC(COC=3C=4C(=O)C5=CC=CC=C5C=4C=CC=3)=CC=2)C=CC=1OC(C(=O)O)C1=CC=CC=C1 QQNUVDFADZMUMM-UHFFFAOYSA-N 0.000 claims 1
- WHASZUKPNPIWMA-UHFFFAOYSA-N 2-[4-[4-[2-(1,3-benzoxazol-2-yl)phenyl]phenyl]phenoxy]-2-phenylacetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C(=CC=CC=2)C=2OC3=CC=CC=C3N=2)C=CC=1OC(C(=O)O)C1=CC=CC=C1 WHASZUKPNPIWMA-UHFFFAOYSA-N 0.000 claims 1
- FYGNDRLHDRXPDZ-UHFFFAOYSA-N 2-[[4-(4-dibenzofuran-4-ylphenyl)phenyl]methoxyimino]-2-phenylacetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C=3OC4=CC=CC=C4C=3C=CC=2)C=CC=1CON=C(C(=O)O)C1=CC=CC=C1 FYGNDRLHDRXPDZ-UHFFFAOYSA-N 0.000 claims 1
- YGUFREKTZUPJMX-UHFFFAOYSA-N 2-[[4-(4-dibenzofuran-4-ylphenyl)phenyl]sulfonylamino]-2-phenylacetic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=C(C4=CC=CC=C4O3)C=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)C1=CC=CC=C1 YGUFREKTZUPJMX-UHFFFAOYSA-N 0.000 claims 1
- IPAXGSIXWVRGDU-UHFFFAOYSA-N 2-[[4-(4-dibenzofuran-4-ylphenyl)phenyl]sulfonylamino]-3-phenylpropanoic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=C(C4=CC=CC=C4O3)C=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CC1=CC=CC=C1 IPAXGSIXWVRGDU-UHFFFAOYSA-N 0.000 claims 1
- JBPANPVYVLBQAD-UHFFFAOYSA-N 2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]-2-fluorophenyl]sulfonyl-methylamino]-3-phenylpropanoic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)C=C(F)C=1S(=O)(=O)N(C)C(C(O)=O)CC1=CC=CC=C1 JBPANPVYVLBQAD-UHFFFAOYSA-N 0.000 claims 1
- LJPVNLNUYKHZES-UHFFFAOYSA-N 2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]-2-fluorophenyl]sulfonylamino]-3-phenylpropanoic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)C=C(F)C=1S(=O)(=O)NC(C(=O)O)CC1=CC=CC=C1 LJPVNLNUYKHZES-UHFFFAOYSA-N 0.000 claims 1
- YPIRSCGUZYBDQH-UHFFFAOYSA-N 2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]sulfonyl-[[3-(trifluoromethyl)phenyl]methyl]amino]butanoic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)C=CC=1S(=O)(=O)N(C(CC)C(O)=O)CC1=CC=CC(C(F)(F)F)=C1 YPIRSCGUZYBDQH-UHFFFAOYSA-N 0.000 claims 1
- NHIMACVYYZIWJC-UHFFFAOYSA-N 2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]sulfonyl-ethylamino]-3-(4-fluorophenyl)propanoic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)C=CC=1S(=O)(=O)N(CC)C(C(O)=O)CC1=CC=C(F)C=C1 NHIMACVYYZIWJC-UHFFFAOYSA-N 0.000 claims 1
- ZVKRFSNAJWLMPK-UHFFFAOYSA-N 2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]sulfonylamino]-3-(3-fluorophenyl)propanoic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CC1=CC=CC(F)=C1 ZVKRFSNAJWLMPK-UHFFFAOYSA-N 0.000 claims 1
- MXGLLBXKUZEPRM-UHFFFAOYSA-N 2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]sulfonylamino]-3-(4-fluorophenyl)propanoic acid Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)C=CC=1S(=O)(=O)NC(C(=O)O)CC1=CC=C(F)C=C1 MXGLLBXKUZEPRM-UHFFFAOYSA-N 0.000 claims 1
- RSVSZFODKAFGLI-UHFFFAOYSA-N 2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]sulfonylamino]-4-methylpentanoic acid Chemical compound C1=CC(S(=O)(=O)NC(CC(C)C)C(O)=O)=CC=C1C1=CC=C(C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)C=C1 RSVSZFODKAFGLI-UHFFFAOYSA-N 0.000 claims 1
- XYZCEZUHZMQLDP-UHFFFAOYSA-N 2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]sulfonylamino]propanoic acid Chemical compound C1=CC(S(=O)(=O)NC(C)C(O)=O)=CC=C1C1=CC=C(C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)C=C1 XYZCEZUHZMQLDP-UHFFFAOYSA-N 0.000 claims 1
- NQDPPXMOGTWHAA-UHFFFAOYSA-N 2-benzyl-4-[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]-4-oxobutanoic acid Chemical compound C=1C=CC=CC=1CC(C(=O)O)CC(=O)C(C=C1)=CC=C1C(C=C1)=CC=C1C(C1=CC=CC=C1O1)=C1CC1=CC=CC=C1 NQDPPXMOGTWHAA-UHFFFAOYSA-N 0.000 claims 1
- CNEKYBTXUMIHHG-UHFFFAOYSA-N 3-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]benzoyl]amino]butanoic acid Chemical compound C1=CC(C(=O)NC(CC(O)=O)C)=CC=C1C1=CC=C(C=2C3=CC=CC=C3OC=2CC=2C=CC=CC=2)C=C1 CNEKYBTXUMIHHG-UHFFFAOYSA-N 0.000 claims 1
- XWPMVHQMDVXBDB-UHFFFAOYSA-N 4-(4-dibenzofuran-4-ylphenyl)-4-oxo-2-[[3-(trifluoromethyl)phenyl]methyl]butanoic acid Chemical compound C=1C=C(C=2C3=C(C4=CC=CC=C4O3)C=CC=2)C=CC=1C(=O)CC(C(=O)O)CC1=CC=CC(C(F)(F)F)=C1 XWPMVHQMDVXBDB-UHFFFAOYSA-N 0.000 claims 1
- BVVWCVAFOUVSLH-UHFFFAOYSA-N C=1C=C(C=2C=CC(=CC=2)C=2C=3OC4=CC=CC=C4C=3C=CC=2)C=CC=1CON=C(CC(=O)O)C1=CC=CC=C1 Chemical compound C=1C=C(C=2C=CC(=CC=2)C=2C=3OC4=CC=CC=C4C=3C=CC=2)C=CC=1CON=C(CC(=O)O)C1=CC=CC=C1 BVVWCVAFOUVSLH-UHFFFAOYSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 125000005098 aryl alkoxy carbonyl group Chemical group 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- JVRMASRCOAIISL-DHUJRADRSA-N ethyl (2s)-2-[[4-[4-(2-benzyl-1-benzofuran-3-yl)phenyl]phenyl]sulfonyl-methylamino]-3-phenylpropanoate Chemical compound C([C@@H](C(=O)OCC)N(C)S(=O)(=O)C=1C=CC(=CC=1)C=1C=CC(=CC=1)C=1C2=CC=CC=C2OC=1CC=1C=CC=CC=1)C1=CC=CC=C1 JVRMASRCOAIISL-DHUJRADRSA-N 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 claims 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
- 125000002071 phenylalkoxy group Chemical group 0.000 claims 1
- 125000003884 phenylalkyl group Chemical group 0.000 claims 1
- 125000000168 pyrrolyl group Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46705703P | 2003-04-30 | 2003-04-30 | |
| PCT/US2004/011371 WO2004099168A2 (en) | 2003-04-30 | 2004-04-14 | Substituted carboxylic acids |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006525329A JP2006525329A (ja) | 2006-11-09 |
| JP2006525329A5 true JP2006525329A5 (https=) | 2007-06-21 |
Family
ID=33435014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006509981A Pending JP2006525329A (ja) | 2003-04-30 | 2004-04-14 | 置換カルボン酸類 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7358364B2 (https=) |
| EP (1) | EP1620420A2 (https=) |
| JP (1) | JP2006525329A (https=) |
| KR (1) | KR20060006953A (https=) |
| CN (1) | CN1812977A (https=) |
| AU (1) | AU2004236173B2 (https=) |
| BR (1) | BRPI0409914A (https=) |
| CA (1) | CA2523714A1 (https=) |
| EA (1) | EA200501710A1 (https=) |
| MX (1) | MXPA05011524A (https=) |
| NO (1) | NO20054957L (https=) |
| WO (1) | WO2004099168A2 (https=) |
| ZA (1) | ZA200509631B (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1812977A (zh) | 2003-04-30 | 2006-08-02 | 药物研发有限责任公司 | 取代羧酸 |
| US7582773B2 (en) * | 2003-09-25 | 2009-09-01 | Wyeth | Substituted phenyl indoles |
| FR2869615B1 (fr) * | 2004-05-03 | 2007-11-16 | Merck Sante Soc Par Actions Si | Derives de l'acide butanoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et leurs applications therapeutiques |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| US7772271B2 (en) | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| EP1771169A1 (en) | 2004-07-14 | 2007-04-11 | PTC Therapeutics, Inc. | Methods for treating hepatitis c |
| JP2008507518A (ja) | 2004-07-22 | 2008-03-13 | ピーティーシー セラピューティクス，インコーポレーテッド | Ｃ型肝炎を治療するためのチエノピリジン |
| JP2008518937A (ja) * | 2004-10-28 | 2008-06-05 | ジ インスティチューツ フォー ファーマシューティカル ディスカバリー、エルエルシー | 置換カルボン酸 |
| AU2005307718A1 (en) * | 2004-11-18 | 2006-05-26 | The Institutes For Pharmaceutical Discovery, Llc | Heterocycle substituted carboxylic acids for the treatment of diabetes |
| CN102775396B (zh) | 2005-11-08 | 2014-10-08 | 沃泰克斯药物股份有限公司 | Atp-结合弹夹转运蛋白的杂环调控剂 |
| US7671221B2 (en) | 2005-12-28 | 2010-03-02 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
| ES2394348T3 (es) | 2006-03-29 | 2013-01-30 | Velacor Therapeutics Pty Ltd | Tratamiento de enfermedades neurodegenerativas con selenato |
| US7754739B2 (en) | 2007-05-09 | 2010-07-13 | Vertex Pharmaceuticals Incorporated | Modulators of CFTR |
| WO2008119109A1 (en) | 2007-03-29 | 2008-10-09 | Velacor Therapeutics Pty Ltd | Treatment of neurological disorders |
| CN104447716A (zh) | 2007-05-09 | 2015-03-25 | 沃泰克斯药物股份有限公司 | Cftr调节剂 |
| MX365732B (es) | 2007-12-07 | 2019-06-12 | Vertex Pharma | Procesos para producir acidos cicloalquilcarboxamido-piridin benzoicos. |
| EP3683218B1 (en) | 2007-12-07 | 2024-09-18 | Vertex Pharmaceuticals Incorporated | Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
| NZ720282A (en) | 2008-02-28 | 2017-12-22 | Vertex Pharma | Heteroaryl derivatives as cftr modulators |
| UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
| JP2013523833A (ja) | 2010-04-07 | 2013-06-17 | バーテックス ファーマシューティカルズ インコーポレイテッド | ３−（６−（１−（２，２−ジフルオロベンゾ［ｄ］［１，３］ジオキソール−５−イル）シクロプロパンカルボキサミド）−３−メチルピリジン−２−イル）安息香酸の医薬組成物およびその投与 |
| CA2821900C (en) | 2010-12-17 | 2015-12-08 | Mitsubishi Tanabe Pharma Corporation | Continuous arycyclic compound |
| NZ727015A (en) | 2012-01-25 | 2017-12-22 | Vertex Pharma | Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| ES2690315T3 (es) | 2012-06-15 | 2018-11-20 | Mitsubishi Tanabe Pharma Corporation | Compuestos de imidazol y triazol como inhibidores de DGAT-1 |
| ES2707961T3 (es) | 2013-07-11 | 2019-04-08 | Bristol Myers Squibb Co | Inhibidores de IDO |
| AU2014349010C1 (en) | 2013-11-12 | 2020-08-06 | Vertex Pharmaceuticals Incorporated | Process of preparing pharmaceutical compositions for the treatment of CFTR mediated diseases |
| US20170114049A1 (en) | 2014-04-03 | 2017-04-27 | Bayer Pharma Aktiengesellschaft | 2,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratory tract diseases |
| US20170119776A1 (en) | 2014-04-03 | 2017-05-04 | Bayer Pharma Aktiengesellschaft | Chiral 2,5-disubstituted cyclopentanecarboxylic acid derivatives and use thereof |
| EP3126339A1 (de) | 2014-04-03 | 2017-02-08 | Bayer Pharma Aktiengesellschaft | 2,5-disubstituierte cyclopentancarbonsäuren und ihre verwendung |
| RU2691136C2 (ru) | 2014-11-18 | 2019-06-11 | Вертекс Фармасьютикалз Инкорпорейтед | Способ проведения высокопроизводительной тестовой высокоэффективной жидкостной хроматографии |
| WO2016116497A1 (de) * | 2015-01-20 | 2016-07-28 | Cynora Gmbh | Organische moleküle, insbesondere zur verwendung in optoelektronischen bauelementen |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1176339A (en) * | 1965-12-27 | 1970-01-01 | Lilly Co Eli | Hydrocinnamic Acid Compounds and Processes for making them |
| IL30498A0 (en) | 1967-08-14 | 1968-10-24 | Merck & Co Inc | Process for the preparation of phenyl salicylic acid compounds and intermediates used therein |
| CH542806A (de) * | 1967-10-06 | 1973-10-15 | Ciba Geigy Ag | Verfahren zur Herstellung einer neuen Aryloxyalkansäure und ihrer Salze |
| CH499526A (de) * | 1968-06-06 | 1970-11-30 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen Tetrazolderivaten |
| US3755603A (en) * | 1970-07-01 | 1973-08-28 | Syntex Corp | Biphenylyloxyacetic acids in pharmaceutical compositions |
| DE2205732A1 (de) * | 1972-02-08 | 1973-08-16 | Thomae Gmbh Dr K | Neue 4-(4-biphenylyl)-butensaeurederivate |
| NL7301246A (https=) * | 1972-02-14 | 1973-08-16 | ||
| DE2358789A1 (de) * | 1973-02-07 | 1975-06-05 | Merck Patent Gmbh | Hydratropasaeure-derivate und verfahren zu ihrer herstellung |
| FR2457275A1 (fr) | 1979-05-21 | 1980-12-19 | Fabre Sa Pierre | Acides p-biphenyl-4 methyl-2 buten-3 oiques utiles dans le traitement des rhumatismes |
| TW268952B (https=) | 1993-02-26 | 1996-01-21 | Takeda Pharm Industry Co Ltd | |
| US5789434A (en) * | 1994-11-15 | 1998-08-04 | Bayer Corporation | Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors |
| US5886022A (en) * | 1995-06-05 | 1999-03-23 | Bayer Corporation | Substituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inhibitors |
| CN100413859C (zh) | 1996-01-23 | 2008-08-27 | 盐野义制药株式会社 | 磺化的氨基酸衍生物及含有它的金属蛋白酶抑制剂 |
| SK285353B6 (sk) | 1996-04-12 | 2006-11-03 | G. D. Searle & Co. | Substituované benzénsulfónamidy ako proliečivá COX-2 inhibítorov, farmaceutická kompozícia a spôsobich prípravy a použitia |
| WO1997039748A1 (en) * | 1996-04-19 | 1997-10-30 | Novo Nordisk A/S | Modulators of molecules with phosphotyrosine recognition units |
| IT1290679B1 (it) * | 1997-02-14 | 1998-12-10 | Alfa Wassermann Spa | Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi. |
| WO1999011255A1 (en) | 1997-08-28 | 1999-03-11 | Ono Pharmaceutical Co., Ltd. | Peroxisome proliferator-activated receptor controllers |
| PE20000127A1 (es) | 1997-12-22 | 2000-03-14 | Novartis Ag | Derivado de bencenosulfonamida |
| WO1999046236A1 (en) * | 1998-03-12 | 1999-09-16 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (ptpases) |
| CA2383983C (en) * | 1998-03-31 | 2009-09-29 | The Institutes For Pharmaceutical Discovery, Llc | Substituted indolealkanoic acids |
| EP1077960A1 (en) | 1998-05-12 | 2001-02-28 | American Home Products Corporation | (2-acylaminothiazole-4-yl)acetic acid derivatives |
| ATE228120T1 (de) | 1998-05-12 | 2002-12-15 | Wyeth Corp | Biphenylsulfonylarylcarbonsäuren verwendbar zur behandlung von insulin resistenz und hyperglycemia |
| JP2002514635A (ja) * | 1998-05-12 | 2002-05-21 | アメリカン・ホーム・プロダクツ・コーポレイション | インスリン耐性および高血糖の処置に有用なビフェニルオキソ−酢酸 |
| CA2331056A1 (en) * | 1998-05-12 | 1999-12-02 | Wyeth | 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| US6232322B1 (en) * | 1998-05-12 | 2001-05-15 | American Home Products Corporation | Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| US6221902B1 (en) * | 1998-05-12 | 2001-04-24 | American Home Products Corporation | Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia |
| NZ515086A (en) | 1999-04-28 | 2003-10-31 | Aventis Pharma Gmbh | Di-aryl acid derivatives as PPAR receptor ligands |
| TNSN00139A1 (fr) * | 1999-06-25 | 2005-11-10 | Inst For Pharm Discovery Inc | Acides phenoxyacetiques substitues |
| JP2003528106A (ja) * | 2000-03-22 | 2003-09-24 | メルク フロスト カナダ アンド カンパニー | Ｐｔｐ−１ｂ阻害薬としての硫黄置換アリールジフルオロメチルホスホン酸類 |
| AU2001248765A1 (en) | 2000-04-21 | 2001-11-12 | Shionogi And Co., Ltd. | Oxadiazole derivatives having therapeutic or preventive efficacies against glomerular disorders |
| WO2001083461A1 (en) | 2000-04-28 | 2001-11-08 | Shionogi & Co., Ltd. | Thiazole and oxazole derivatives |
| EP1288199A4 (en) | 2000-04-28 | 2005-10-12 | Shionogi & Co | INHIBITORS OF MMP-12 |
| EP1301516B1 (en) * | 2000-07-07 | 2006-03-22 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (ptpases) |
| WO2002008188A1 (en) | 2000-07-25 | 2002-01-31 | Merck & Co., Inc. | N-substituted indoles useful in the treatment of diabetes |
| US6472545B2 (en) * | 2000-08-29 | 2002-10-29 | Abbott Laboratories | Protein tyrosine phosphatase inhibitors |
| EP1331224A4 (en) | 2000-09-29 | 2004-03-17 | Shionogi & Co | THIAZOLE AND OXAZOLE DERIVATIVES |
| AU2002251978B2 (en) | 2001-02-09 | 2007-07-19 | Merck & Co., Inc. | 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| MXPA03011558A (es) | 2001-06-12 | 2004-03-26 | Wellstat Therapeutics Corp | Compuestos para el tratamiento de desordenes metabolicos. |
| DE10150172A1 (de) | 2001-10-11 | 2003-04-30 | Morphochem Ag | Neue Verbindungen, die Protein Tyrosin Phosphatase 1B (PTP-1B) inhibieren |
| WO2003035610A1 (en) | 2001-10-26 | 2003-05-01 | Shionogi & Co., Ltd. | Sulfonamide derivative having mmp inhibitory activity |
| WO2003048140A1 (en) * | 2001-12-03 | 2003-06-12 | Japan Tobacco Inc. | Azole compound and medicinal use thereof |
| US7297715B2 (en) | 2002-07-30 | 2007-11-20 | Merck & Co., Inc. | PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| WO2004020408A1 (en) | 2002-08-29 | 2004-03-11 | Merck & Co., Inc. | Indoles having anti-diabetic activity |
| BRPI0409447A (pt) | 2003-04-14 | 2006-04-18 | Inst For Pharm Discovery Inc | ácidos fenilalcanóicos substituìdos |
| CN1812977A (zh) | 2003-04-30 | 2006-08-02 | 药物研发有限责任公司 | 取代羧酸 |
| JPWO2005063222A1 (ja) | 2003-12-26 | 2007-07-19 | 協和醗酵工業株式会社 | Ｈｓｐ９０ファミリー蛋白質阻害剤 |
| TW200630327A (en) | 2004-10-28 | 2006-09-01 | Inst For Pharm Discovery Inc | Substituted phenylalkanoic acids |
-
2004
- 2004-04-14 CN CNA2004800184160A patent/CN1812977A/zh active Pending
- 2004-04-14 BR BRPI0409914-1A patent/BRPI0409914A/pt not_active IP Right Cessation
- 2004-04-14 EP EP04760538A patent/EP1620420A2/en not_active Withdrawn
- 2004-04-14 JP JP2006509981A patent/JP2006525329A/ja active Pending
- 2004-04-14 CA CA002523714A patent/CA2523714A1/en not_active Abandoned
- 2004-04-14 MX MXPA05011524A patent/MXPA05011524A/es not_active Application Discontinuation
- 2004-04-14 AU AU2004236173A patent/AU2004236173B2/en not_active Ceased
- 2004-04-14 WO PCT/US2004/011371 patent/WO2004099168A2/en not_active Ceased
- 2004-04-14 EA EA200501710A patent/EA200501710A1/ru unknown
- 2004-04-14 KR KR1020057020613A patent/KR20060006953A/ko not_active Withdrawn
- 2004-04-14 US US10/823,842 patent/US7358364B2/en not_active Expired - Fee Related
-
2005
- 2005-10-25 NO NO20054957A patent/NO20054957L/no not_active Application Discontinuation
- 2005-11-29 ZA ZA200509631A patent/ZA200509631B/en unknown
-
2008
- 2008-04-15 US US12/103,082 patent/US20090082392A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006525329A5 (https=) | ||
| AU2004236173B2 (en) | Substituted carboxylic acids | |
| JP2021176846A (ja) | スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用 | |
| RU2379295C2 (ru) | Производные пиридазинона в качестве агонистов рецептора тиреоидного гормона | |
| NZ531153A (en) | Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient | |
| SK12892001A3 (sk) | Zlúčeniny a prostriedky ako inhibítory proteázy | |
| RU2420522C2 (ru) | Новый класс ингибиторов гистондеацетилаз | |
| EP1308438A1 (en) | 3-substituted urea derivatives and medicinal use thereof | |
| RU2010120682A (ru) | Ингибиторы гистондезацетилазы | |
| BR112014011242A2 (pt) | derivados de aril ureia como moduladores do receptor semelhante ao receptor de n-formil peptídio-1 (fprl-1) | |
| JP2006525364A (ja) | 置換アミノカルボン酸 | |
| RU2010150911A (ru) | Амидное соединение | |
| JP2003527368A (ja) | Ｉｐアンタゴニストとしてのカルボン酸誘導体 | |
| RU2012131341A (ru) | Индол-пиперидинилбензиламины как ингибиторы бета-триптазы | |
| JP2008520693A (ja) | プロテインチロシンホスファターゼ阻害剤としての置換アミノ酸 | |
| HRP20140273T1 (hr) | Premošteni šesteroäślani prstenasti spojevi | |
| RU2015150287A (ru) | Новые соединения 3,4-дигидро-2н-изохинолин-1-она и 2,3-дигидроизоиндол-1-она | |
| SK12452001A3 (sk) | Zlúčenina vytvárajúca inhibítor metaloproteinázy, farmaceutický prostriedok, spôsob prípravy liečiva a liečivo | |
| WO2002020462A1 (en) | Benzoic acid derivatives and drugs containing the same as the active ingredient | |
| JP2005514455A (ja) | 芳香族チオエーテル肝臓ｘ受容体モジュレータ | |
| RS57923B1 (sr) | Nova sulfonilaminobenzamidna jedinjenja | |
| RU2008129641A (ru) | Ингибиторы ccr9 активности | |
| JP2020530479A5 (https=) | ||
| NZ541603A (en) | Carbonyl phenyl propanoic acid derivative compounds | |
| JP2008501740A (ja) | ２−オキソ−１−ピロリジン誘導体の製造方法 |